Haleon plc (LON:HLN)

Market Cap	32.84B
Revenue (ttm)	11.02B
Net Income (ttm)	1.52B
Shares Out	8.99B
EPS (ttm)	0.17
PE Ratio	21.89
Forward PE	19.05
Dividend	0.07 (1.84%)
Ex-Dividend Date	Aug 14, 2025

Volume	22,140,207
Average Volume	21,203,333
Open	357.40
Previous Close	359.50
Day's Range	357.40 - 368.50
52-Week Range	346.10 - 419.50
Beta	0.22
RSI	46.24
Earnings Date	Jul 31, 2025

About Haleon

Haleon plc, together with its subsidiaries, engages in the research, development, manufacture, and sale of various consumer healthcare products in North America, Europe, the Middle East, Africa, Latin America, and the Asia Pacific. The company offers oral health products, such as toothpastes, mouth washes, and denture care products under the Sensodyne, Polident, Parodontax, Aquafresh, and Biotene brands; and vitamins, minerals, and supplements under Centrum, Emergen-C, Caltrate brands. It also provides various over-the-counter products comprisi...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1715
• Employees: 24,561
• Stock Exchange: London Stock Exchange
• Ticker Symbol: HLN

Financial Performance

In 2024, Haleon's revenue was 11.23 billion, a decrease of -0.61% compared to the previous year's 11.30 billion. Earnings were 1.44 billion, an increase of 37.46%.